PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
PVCT.WS was delisted on the 13th of October, 2016.
4 hedge funds and large institutions have $1.21M invested in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$457K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$424K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$156K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$120K |
Top Sellers
PVCT.WS Hedge Fund Activity: Q2 2015 in Review
4 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) for Q2 2015, worth a combined $1.21M.
Buyers outnumbered sellers: 4 funds opened new PVCT.WS positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $457K.
- 4 institutional investors held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $1.21M of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) stock for Q2 2015.
- 4 funds opened new PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) positions in Q2 2015 and 0 closed out, a net change of +4 holders.
- The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) buyer in Q2 2015 was Cormorant Asset Management, an estimated $457K added.
Based on aggregated 13F filings for Q2 2015.